Cannabis Products from Colombia Shipped to Brazil by Courier
Release met the needs of some companies that had been without shipments since August
Published on 11/19/2025

Meeting of the National Federation of Cannabis Entities (FNE) with sector representatives, held in October 2025, discussed logistical solutions to unblock imports and improve the delivery process of cannabis products to Brazil | Image
Cannabis-based products, imported for Brazilian patients, arrived in São Paulo last Friday (15) via an express shipping system that significantly reduces delivery time. The speed of transportation is crucial to ensure the continuity of treatment for patients in Brazil who rely on the regular importation of these items.
The shipments, primarily from Colombia, have their export monitored by the National Drug Fund (FNE).
Since August, some companies had their imports stalled, causing delays and insecurity for patients who depend on these medications. Now, with the release, the shipment that arrived in Brazil serves about 50 patients who were waiting for cannabis-based products.
“It is important because the shipments are much faster. It is possible to provide more agility for patients waiting for medications here in Brazil, in addition to reducing the time at the origin,” highlighted Fernanda Vanzeli, commercial manager of Courier Brasil Express.
According to the manager, the shipments were being released through formal dispatch, the traditional export standard. In this format, the shipment took 3 to 7 days to be completed, and upon arriving in Brazil, the product still needed to go through the release times of Anvisa and the Federal Revenue — a process that could take, on average, an additional 3 to 7 days, reaching up to 15 days before the medication reached the patient.
With the courier modality, shipments are treated as urgent (express) deliveries, being completed in up to two days and the process is simplified.
“Now we can meet the deadlines. The intermediary wants to ensure that the patient receives the medication within the expected time,” Vanzeli emphasized.
The authorized shipment is expected to serve about 50 patients who were waiting for cannabis-based therapeutic products.


